Tenax Therapeutics
TENX
23 hedge funds and large institutions have $13.1M invested in Tenax Therapeutics in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
56% more capital invested
Capital invested by funds: $8.43M → $13.1M (+$4.69M)
10.59% more ownership
Funds ownership: 39.95% → 50.54% (+11%)
10% more funds holding
Funds holding: 21 → 23 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$2.43M |
| 2 |
IHAM
Integral Health Asset Management
New York
|
+$1.07M |
| 3 |
Morgan Stanley
New York
|
+$299K |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$218K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$148K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$83.7K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$11.3K |
| 3 |
VPC
Vestal Point Capital
New York
|
-$11.2K |
| 4 |
Millennium Management
New York
|
-$1.17K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$31 |
TENX Hedge Fund Activity: Q1 2025 in Review
23 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2025, worth a combined $13.1M — up 56% from $8.43M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TENX positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $2.43M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $83.7K sold.
- 23 institutional investors held Tenax Therapeutics (TENX) as of Q1 2025, up from 21 in Q4 2024.
- Funds reported $13.1M of Tenax Therapeutics stock for Q1 2025, up 56% quarter-over-quarter.
- 4 funds opened new Tenax Therapeutics positions in Q1 2025 and 2 closed out, a net change of +2 holders.
- The largest Tenax Therapeutics buyer in Q1 2025 was RTW Investments, an estimated $2.43M added.
- The largest Tenax Therapeutics seller in Q1 2025 was Two Sigma Investments, an estimated $83.7K sold.
Based on aggregated 13F filings for Q1 2025.